Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market to Reach $1.74 Billion by 2029, Growing at a CAGR of 6.6%

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Industry In 2025?

The market encompassing devices and apparatus for addressing benign prostatic hyperplasia (BPH) has demonstrated robust expansion throughout the recent past, projected to advance from a valuation of $1.27 billion in 2024 to $1.34 billion the following year, reflecting a steady compound annual growth rate (CAGR) of 5.9%; this upward trajectory observed during the historical timeframe is fundamentally linked to factors such as the increasing longevity of the population, heightened levels of recognition and diagnostic capabilities, improved availability of medical services, and the trend towards patient-specific therapeutic approaches.

The market encompassing devices and apparatus for treating benign prostatic hyperplasia (BPH) anticipates robust expansion across the coming years, projecting an increase to $\$1.74$ billion by 2029, propelled by a compound annual growth rate (CAGR) of $6.6\%$. Factors contributing to this upward trajectory during the projection timeframe encompass the rising adoption of less invasive methodologies, expansion within nascent economies, beneficial regulatory environments, and a shift towards value-based healthcare models. Key developments anticipated throughout this forecast span involve the proliferation of procedures conducted outside of traditional surgical settings and within outpatient offices, advancements in laser and radiofrequency technology applications, the integration of telemedicine and remote patient consultations, and heightened focus on patient comprehension and involvement.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Industry?

Elevated incidences of prostate cancer are forecasted to propel the expansion of the market concerned with benign prostatic hyperplasia in the future. Prostate cancer, a malignancy originating in the prostate gland—a small gland beneath the bladder in males—when more prevalent, frequently causes a greater volume of aging men to seek clinical evaluation for prostate conditions, consequently facilitating the diagnosis and subsequent treatment of benign prostatic hyperplasia; evidence from February 2023, as cited by the American Society of Clinical Oncology (ASCO)—a US professional body maintaining patient resources on cancer dot net—suggested approximately 288,300 men across the United States were living with prostate cancer in 2023, following 268,490 new diagnoses and 34,500 fatalities attributed to the disease in the preceding year, illustrating how the rising count of prostate cancer patients directly fuels the progression of the benign prostatic hyperplasia market.

How Is The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Classified Into Different Segments?

The benign prostatic hyperplasia (bph) treatment devices and equipmentmarket covered in this report is segmented –

1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants

2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types

3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home

Subsegments:

1) By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes

2) By Radiofrequency Ablation Device: Single-Needle Radiofrequency Ablation, Multi-Needle Radiofrequency Ablation

3) By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers

4) By Prostatic Stents: Temporary Prostatic Stents, Permanent Prostatic Stents

5) By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, Permanent Implants for BPH Treatment

Which Market Trends Are Creating New Opportunities In The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Industry?

Leading firms within the benign prostatic hyperplasia sphere prioritize the creation of cutting-edge offerings, exemplified by the UroLift 2 System and the UroLift ATC sophisticated tissue management apparatus, aiming to deliver dependable solutions to the sector; these specific tools, the UroLift 2 System and the UroLift ATC advanced tissue control system, have been introduced specifically for managing the lower urinary tract manifestations associated with BPH. For illustration, in May of 2022, Teleflex Incorporated, a medical technology entity headquartered in the United States, released both the UroLift 2 System and the UroLift ATC, wherein the UroLift 2 System functions as a deployment mechanism intended to reach the prostatic urethra and insert durable UroLift implants into the prostate lobes, while the UroLift ATC advanced tissue control system represents a procedure requiring minimal invasiveness for addressing symptoms stemming from an enlarged prostate; fundamentally, this constitutes a progressive methodology for BPH therapy, involving the lifting and securing of enlarged prostatic matter so that it ceases obstructing the urethra.

Who Are The Prominent Global Companies Shaping The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?

Major companies operating in the benign prostatic hyperplasia (BPH) treatment devices and equipment market include Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston scientific Inc., Endo International plc, NeoTract Inc., OmniGuide Inc., Medifocus Inc., ProArc Medical Ltd., Teleflex Incorporated, Medtronic plc, Urotech Devices, Prostalund Operations AB, Baxter International, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Siemens Healthineers, Quest Pharmatech, Protox Therapeutics, IntelGenx Technologies Corp, Astellas Pharma Inc., Ipsen S.A., Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, Merit Medical Systems, Pnn Medical A/S, PROCEPT BioRobotics, Prosenex, ProSolv CardioVascular Inc., Quanta System, Rocamed SAM, RZ Medizintechnik GmbH, SRS Medical Systems, UroShape LLC, Vertebron Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

How Do Regional Market Performances Compare Within The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Industry?

North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2024. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (BNH) treatment devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Request A Customized Version Of The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2431&type=smp

Browse Through More Reports Similar to the Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market 2025, By The Business Research Company

Prostate Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report

Radiofrequency Identification Tags Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/radiofrequency-identification-tags-global-market-report

Tumor Ablation Therapy Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info